SI2014771T1 - Kontinuiran postopek encimske hidrolize - Google Patents
Kontinuiran postopek encimske hidrolizeInfo
- Publication number
- SI2014771T1 SI2014771T1 SI200731620T SI200731620T SI2014771T1 SI 2014771 T1 SI2014771 T1 SI 2014771T1 SI 200731620 T SI200731620 T SI 200731620T SI 200731620 T SI200731620 T SI 200731620T SI 2014771 T1 SI2014771 T1 SI 2014771T1
- Authority
- SI
- Slovenia
- Prior art keywords
- enzymatic hydrolysis
- hydrolysis process
- continuous enzymatic
- continuous
- hydrolysis
- Prior art date
Links
- 230000007071 enzymatic hydrolysis Effects 0.000 title 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
- C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07110957.3A EP2014771B1 (en) | 2007-06-25 | 2007-06-25 | Continuous enzymatic hydrolysis process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2014771T1 true SI2014771T1 (sl) | 2015-04-30 |
Family
ID=39111421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200731620T SI2014771T1 (sl) | 2007-06-25 | 2007-06-25 | Kontinuiran postopek encimske hidrolize |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110091943A1 (sl) |
| EP (1) | EP2014771B1 (sl) |
| JP (1) | JP5559046B2 (sl) |
| CN (1) | CN101720333B (sl) |
| AU (1) | AU2008268384B2 (sl) |
| CA (1) | CA2692437C (sl) |
| DK (1) | DK2014771T3 (sl) |
| ES (1) | ES2530763T3 (sl) |
| MX (1) | MX2009014280A (sl) |
| PL (1) | PL2014771T3 (sl) |
| SI (1) | SI2014771T1 (sl) |
| TW (1) | TWI438280B (sl) |
| WO (1) | WO2009003042A1 (sl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT201800662T1 (it) | 2011-12-22 | 2019-01-11 | Alios Biopharma Inc | Nucleotidi, nucleosidi sostituiti e loro analoghi |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| PL2861611T3 (pl) | 2012-05-25 | 2017-08-31 | Janssen Sciences Ireland Uc | Nukleozydy uracylowe spirooksetanu |
| EP3912984A1 (en) | 2012-12-21 | 2021-11-24 | Janssen BioPharma, Inc. | 4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv |
| SG10201804835VA (en) | 2013-10-11 | 2018-07-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| CA3182565A1 (en) | 2015-03-06 | 2016-09-15 | Atea Pharmaceuticals, Inc. | .beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment |
| EP3865136A1 (en) | 2016-09-07 | 2021-08-18 | ATEA Pharmaceuticals, Inc. | 2'-substituted-n6-substituted purine nucleotides for corona virus treatment |
| FI3577124T3 (fi) | 2017-02-01 | 2025-02-13 | Atea Pharmaceuticals Inc | Nukleotidihemisulfaattisuola hepatiitti C -viruksen hoitoon |
| KR20200140865A (ko) | 2018-04-10 | 2020-12-16 | 아테아 파마슈티컬즈, 인크. | 간경변증을 갖는 hcv 감염 환자의 치료 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| MX2023014898A (es) | 2021-06-17 | 2024-04-29 | Atea Pharmaceuticals Inc | Terapia combinada anti-vhc ventajosa. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3836432A (en) * | 1969-09-25 | 1974-09-17 | Hokkaido Sugar Co | Continuous process for the hydrolysis of raffinose |
| FR2648147B1 (fr) * | 1989-06-13 | 1991-08-16 | Gattefosse Ets Sa | Procede pour la preparation de beta-monoglycerides et produits obtenus |
| US5538891A (en) * | 1991-09-02 | 1996-07-23 | Boehringer Mannheim Gmbh | Process for enzymatic production of isomerically pure isosorbide-2 and 5-monoesters and their conversion to isosorbide-2 and -5 nitrate |
| US5686426A (en) * | 1994-11-17 | 1997-11-11 | Bristol-Myers Squibb Company | Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| US6833471B2 (en) * | 2002-09-09 | 2004-12-21 | Biocatalytics, Inc. | Methods for producing hydroxy amino acids and derivatives thereof |
| CN1964985A (zh) * | 2004-06-07 | 2007-05-16 | 阿纳迪斯药物公司 | 3－β－D－呋喃核糖基噻唑并[4,5－d]嘧啶核苷类及其应用 |
| DE102005002700A1 (de) * | 2005-01-19 | 2006-07-27 | Cognis Deutschland Gmbh & Co. Kg | Zusammensetzungen verwendbar als Biotreibstoff |
-
2007
- 2007-06-25 ES ES07110957T patent/ES2530763T3/es active Active
- 2007-06-25 EP EP07110957.3A patent/EP2014771B1/en not_active Not-in-force
- 2007-06-25 SI SI200731620T patent/SI2014771T1/sl unknown
- 2007-06-25 DK DK07110957T patent/DK2014771T3/en active
- 2007-06-25 PL PL07110957T patent/PL2014771T3/pl unknown
-
2008
- 2008-06-24 TW TW097123430A patent/TWI438280B/zh not_active IP Right Cessation
- 2008-06-25 JP JP2010515081A patent/JP5559046B2/ja not_active Expired - Fee Related
- 2008-06-25 CA CA2692437A patent/CA2692437C/en not_active Expired - Fee Related
- 2008-06-25 WO PCT/US2008/068197 patent/WO2009003042A1/en not_active Ceased
- 2008-06-25 CN CN2008800216422A patent/CN101720333B/zh not_active Expired - Fee Related
- 2008-06-25 MX MX2009014280A patent/MX2009014280A/es active IP Right Grant
- 2008-06-25 AU AU2008268384A patent/AU2008268384B2/en not_active Ceased
- 2008-06-25 US US12/666,597 patent/US20110091943A1/en not_active Abandoned
-
2013
- 2013-01-22 US US13/747,138 patent/US20130137143A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009003042A1 (en) | 2008-12-31 |
| AU2008268384A1 (en) | 2008-12-31 |
| CN101720333A (zh) | 2010-06-02 |
| CA2692437C (en) | 2016-04-19 |
| CN101720333B (zh) | 2012-08-29 |
| CA2692437A1 (en) | 2008-12-31 |
| US20110091943A1 (en) | 2011-04-21 |
| DK2014771T3 (en) | 2015-03-09 |
| MX2009014280A (es) | 2010-06-23 |
| TWI438280B (zh) | 2014-05-21 |
| PL2014771T3 (pl) | 2015-05-29 |
| ES2530763T3 (es) | 2015-03-05 |
| HK1126820A1 (en) | 2009-09-11 |
| JP2011500001A (ja) | 2011-01-06 |
| US20130137143A1 (en) | 2013-05-30 |
| EP2014771B1 (en) | 2014-12-03 |
| EP2014771A1 (en) | 2009-01-14 |
| AU2008268384B2 (en) | 2013-09-26 |
| JP5559046B2 (ja) | 2014-07-23 |
| TW200911997A (en) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2014771T1 (sl) | Kontinuiran postopek encimske hidrolize | |
| SG10201506935QA (en) | Enzymatic process | |
| GB0715101D0 (en) | Process | |
| GB0706978D0 (en) | Process | |
| GB0711624D0 (en) | Process | |
| GB0716126D0 (en) | Process | |
| PL2772543T3 (pl) | Enzymatyczny proces wytwarzania beta-santalenu i odpowiadającego mu enzymu | |
| GB0711680D0 (en) | Process | |
| EP2229583A4 (en) | Monitoring enzymatic process | |
| IL190914A0 (en) | Production of dolasetron | |
| GB0700074D0 (en) | process | |
| GB0714390D0 (en) | Process | |
| GB0804721D0 (en) | Enzyme | |
| GB0700878D0 (en) | Process | |
| GB0818328D0 (en) | Novel enzyme | |
| GB0724716D0 (en) | Process | |
| GB0709689D0 (en) | Process | |
| GB0804722D0 (en) | Enzyme | |
| GB0800831D0 (en) | Enzymes 1 | |
| GB0701966D0 (en) | Process | |
| HU0700089D0 (en) | Hydrolysis | |
| AU2008903814A0 (en) | Enzyme hydrolysis method | |
| GB0910808D0 (en) | Enzymatic process | |
| GB0903266D0 (en) | Enzymatic process | |
| GB0800832D0 (en) | Enzymes 2 |